mifepristone has been researched along with Colorectal Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YH; Jang, JH; Kim, SH; Kwon, TK; Lee, TJ; Min, KJ; Park, EJ; Um, HJ; Woo, SM | 1 |
| Chen, W; Dong, H; Gao, Y; Gu, S; Jia, L; Lu, Y; Sinko, PJ; Xie, X; Yu, T; Zhang, H; Zhang, Y; Zhu, Y | 1 |
| Alzuguren, P; Berraondo, P; Crettaz, J; Gonzalez-Aparicio, M; Gonzalez-Aseguinolaza, G; Hernandez-Alcoceba, R; Hervas-Stubbs, S; Mancheno, U; Mauleon, I; Medina-Echeverz, J; Prieto, J | 1 |
| Bo, L; Fan, J; Gu, J; Li, B; Liu, X; Qi, R; Qian, C | 1 |
| Adachi, Y; Ikehara, S; Iwasaki, M; Kamiyama, Y; Koike-Kiriyama, N; Mukaide, H; Shi, M; Shigematsu, A; Taketani, S; Yanai, S; Yoshioka, K | 1 |
5 other study(ies) available for mifepristone and Colorectal Neoplasms
| Article | Year |
|---|---|
RU486, a glucocorticoid receptor antagonist, induces apoptosis in U937 human lymphoma cells through reduction in mitochondrial membrane potential and activation of p38 MAPK.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Cytochromes c; Enzyme Activation; Female; HCT116 Cells; Hormone Antagonists; Humans; Leukemia; Lung Neoplasms; Lymphoma; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mifepristone; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Glucocorticoid; U937 Cells | 2013 |
The Architecture and Function of Monoclonal Antibody-Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention.
Topics: Abortifacient Agents, Steroidal; Absorption, Physicochemical; Animals; Antibodies, Monoclonal; Apoptosis; Colorectal Neoplasms; Diffusion; Drug Delivery Systems; Drug Repositioning; Epithelial Cell Adhesion Molecule; HT29 Cells; Humans; Mice; Mifepristone; Nanocapsules; Nanoconjugates; Nanopores; Silicon Dioxide; Treatment Outcome | 2016 |
Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice.
Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Down-Regulation; Female; Genetic Therapy; Genetic Vectors; Immune Tolerance; Interleukin-12; Liver; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Nude; Mifepristone; Organoplatinum Compounds; Oxaliplatin; Transduction, Genetic; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2011 |
Suppression of colorectal tumor growth by regulated survivin targeting.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Caspases; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genes, Dominant; Genes, Reporter; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Luciferases; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Mifepristone; Neoplasm Proteins; Promoter Regions, Genetic; Random Allocation; Survivin; Telomerase; Time Factors; Transfection; Xenograft Model Antitumor Assays | 2006 |
FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma.
Topics: Adenocarcinoma; Cell Division; Colon; Colorectal Neoplasms; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Methylprednisolone; Mifepristone; Neoplasm Proteins; Receptors, Glucocorticoid; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Tacrolimus Binding Proteins; Tumor Cells, Cultured | 2008 |